Search - tctmd.com

Displaying 1 - 20 of 165

Sort: Relevancy | Date

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation NY Valves 2025

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Presenter: Yasser M. Sammour

June 25, 2025

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2023

Call to Action: Recommendations for Strengthening the Partnership Between Patients and Clinicians

Presenter: Susan Strong

October 23, 2023

Presentation TVT 2023

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

Presenter: Mayra Guerrero

June 10, 2023

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

Presentation TCT 2020

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Presenter: Rebecca T. Hahn

October 17, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Presentation TCT 2019

Industry Perspective on Drug-Eluting Technologies Guidance

Presenter: Mark Pacyna

September 25, 2019

Presentation TCT 2019

FDA Perspective and Revised Guidance

Presenter: Eleni Whatley

September 25, 2019

Presentation TCT 2019

New Data Regarding Drug-Eluting Technologies

Presenter: Krishna Rocha-Singh

September 25, 2019

Presentation TCT 2019

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

Presenter: Michael Jaff

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presenter: Eric Dippel

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 2: My Toughest Case From the Last Year

Presenter: Peter Soukas

September 25, 2019

Presentation TCT 2019

Complex CLI Case Review 1: My Best Case From the Last Year

Presenter: Venita Chandra

September 25, 2019

Presentation TCT 2019

CLI Diagnostics and Real-Time Guidance: What's New in 2019

Presenter: Matthew Menard

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Presenter: Ehrin Armstrong

September 25, 2019

Advertisement

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Call to Action: Recommendations for Strengthening the Partnership Between Patients and Clinicians

Bioprosthetic Surgical Valves in Intermediate-risk Patients: 1-Year Outcomes of the PARTNER 3 Mitral Valve-in-Valve Study

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Industry Perspective on Drug-Eluting Technologies Guidance

FDA Perspective and Revised Guidance

New Data Regarding Drug-Eluting Technologies

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

Complex CLI Case Review 3: What Is Possible in the OBL?

Complex CLI Case Review 2: My Toughest Case From the Last Year

Complex CLI Case Review 1: My Best Case From the Last Year

CLI Diagnostics and Real-Time Guidance: What's New in 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content